| __timestamp | Galapagos NV | Verona Pharma plc |
|---|---|---|
| Wednesday, January 1, 2014 | 9079000 | 1802274 |
| Thursday, January 1, 2015 | 20309000 | 2512761 |
| Friday, January 1, 2016 | 16945000 | 2894488 |
| Sunday, January 1, 2017 | 20559000 | 8096274 |
| Monday, January 1, 2018 | 29641000 | 7985229 |
| Tuesday, January 1, 2019 | 88258000 | 8994597 |
| Wednesday, January 1, 2020 | 162170000 | 29772000 |
| Friday, January 1, 2021 | 167218000 | 33907000 |
| Saturday, January 1, 2022 | 239528000 | 26579000 |
| Sunday, January 1, 2023 | 94252000 | 49868547 |
Igniting the spark of knowledge
In the competitive world of biotechnology, managing operational costs is crucial for success. This chart compares the Selling, General, and Administrative (SG&A) expenses of Verona Pharma plc and Galapagos NV from 2014 to 2023. Over this period, Galapagos NV consistently outspent Verona Pharma plc, with its SG&A expenses peaking in 2022 at approximately 240% higher than its 2014 levels. In contrast, Verona Pharma plc's expenses showed a more modest increase, reaching their highest in 2023, nearly 27 times their 2014 figure. This disparity highlights the differing strategic approaches of these companies, with Galapagos NV investing heavily in administrative and sales functions, while Verona Pharma plc maintains a more conservative expenditure strategy. Understanding these trends provides valuable insights into each company's operational priorities and market positioning.
Breaking Down SG&A Expenses: Johnson & Johnson vs Galapagos NV
Breaking Down SG&A Expenses: Intra-Cellular Therapies, Inc. vs Verona Pharma plc
Who Optimizes SG&A Costs Better? Insmed Incorporated or Galapagos NV
Operational Costs Compared: SG&A Analysis of BioMarin Pharmaceutical Inc. and Verona Pharma plc
Selling, General, and Administrative Costs: Madrigal Pharmaceuticals, Inc. vs Verona Pharma plc
Who Optimizes SG&A Costs Better? Verona Pharma plc or MorphoSys AG
Who Optimizes SG&A Costs Better? Verona Pharma plc or Supernus Pharmaceuticals, Inc.
Rhythm Pharmaceuticals, Inc. and Galapagos NV: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing MorphoSys AG and Galapagos NV
Who Optimizes SG&A Costs Better? Ligand Pharmaceuticals Incorporated or Galapagos NV
Breaking Down SG&A Expenses: Mesoblast Limited vs Galapagos NV
Cost Management Insights: SG&A Expenses for Dynavax Technologies Corporation and Galapagos NV